Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
Monoisotopic mass
372.100739147
InChI
InChI=1S/C18H22O5S.Na/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19;/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22);/q;+1/p-1/t14-,15-,16+,18+;/m1./s1
InChI Key
InChIKey=VUCAHVBMSFIGAI-ZFINNJDLSA-M
IUPAC Name
sodium (1S,10R,11S,15S)-15-methyl-14-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2,4,6-trien-5-yl sulfate
Traditional IUPAC Name
sodium estrone 3-sulfate
SMILES
[Na+].[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=CC=C(OS([O-])(=O)=O)C=C3CC[C@@]21[H]
pKa (strongest acidic)
-1.7
pKa (Strongest Basic)
-7.5
Refractivity
87.95 m3·mol-1
Dược Lực Học :
Conjugated estrogens, a mixture of the water soluble salts of sulfate esters from estrone, equilin, 17 α-dihydroequilin, and other related steroids, may be derived from pregnant equine urine or yam and soy plants. Estrogens are important in the development and maintenance of the female reproductive system and secondary sex characteristics. They promote growth and development of the vagina, uterus, and fallopian tubes, and enlargement of the breasts. Indirectly, they contribute to the shaping of the skeleton, maintenance of tone and elasticity of urogenital structures, changes in the epiphyses of the long bones that allow for the pubertal growth spurt and its termination, growth of axillary and pubic hair, and pigmentation of the nipples and genitals. Decline of estrogenic activity at the end of the menstrual cycle can bring on menstruation, although the cessation of progesterone secretion is the most important factor in the mature ovulatory cycle. However, in the preovulatory or nonovulatory cycle, estrogen is the primary determinant in the onset of menstruation. Estrogens also affect the release of pituitary gonadotropins. The pharmacologic effects of conjugated estrogens are similar to those of endogenous estrogens.
Cơ Chế Tác Dụng :
Conjugated estrogens, a mixture of the water-soluble salts of sulfate esters from estrone, equilin, 17 α-dihydroequilin, and other related steroids, may be derived from pregnant equine urine or yam and soy plants. Estrogens are important in the development and maintenance of the female reproductive system and secondary sex characteristics.
Estrogens enter the cells of responsive tissues (e.g., female organs, breasts, hypothalamus, pituitary) where they interact with a protein receptor, subsequently increasing the rate of synthesis of DNA, RNA, and some proteins. Estrogens decrease the secretion of gonadotropin-releasing hormone by the hypothalamus, reducing the secretion of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary.
Dược Động Học :
▧ Absorption :
Well absorbed
▧ Protein binding :
90% bound to plasma proteins
▧ Metabolism :
Hepatic
▧ Route of Elimination :
Estradiol, estrone, and estriol are excreted in the urine, along with glucuronide and sulfate conjugates. Exogenous estrogens are metabolized in the same manner as endogenous estrogens.
▧ Half Life :
7.4 hours
Độc Tính :
Nausea and vomiting
Chỉ Định :
For the treatment of moderate to severe vasomotor symptoms associated with the menopause, atrophic vaginitis, osteoporosis, hypoestrogenism due to hypogonadism, castration, primary ovarian failure, breast cancer (for palliation only), and Advanced androgen-dependent carcinoma of the prostate (for palliation only)
Tương Tác Thuốc :
-
Amobarbital
The enzyme inducer, amobarbital, decreases the effect of the hormone agent, conjugated estrogens.
-
Aprobarbital
The enzyme inducer, aprobarbital, decreases the effect of the hormone agent, conjugated estrogens.
-
Butabarbital
The enzyme inducer, butabarbital, decreases the effect of the hormone agent, conjugated estrogens.
-
Butalbital
The enzyme inducer, butalbital, decreases the effect of the hormone agent, conjugated estrogens.
-
Butethal
The enzyme inducer, butethal, decreases the effect of the hormone agent, conjugated estrogens.
-
Ethotoin
The enzyme inducer, ethotoin, decreases the effect of the hormone agent, conjugated estrogens.
-
Fosphenytoin
The enzyme inducer, fosphenytoin, decreases the effect of the hormone agent, conjugated estrogens.
-
Griseofulvin
The enzyme inducer, griseofulvin, decreases the effect of the hormone agent, conjugated estrogens.
-
Heptabarbital
The enzyme inducer, heptabarbital, decreases the effect of the hormone agent, conjugated estrogens.
-
Hexobarbital
The enzyme inducer, hexobarbital, decreases the effect of the hormone agent, conjugated estrogens.
-
Mephenytoin
The enzyme inducer, mephenytoin, decreases the effect of the hormone agent, conjugated estrogens.
-
Methohexital
The enzyme inducer, methohexital, decreases the effect of the hormone agent, conjugated estrogens.
-
Methylphenobarbital
The enzyme inducer, methylphenobarbital, decreases the effect of the hormone agent, conjugated estrogens.
-
Pentobarbital
The enzyme inducer, pentobarbital, decreases the effect of the hormone agent, conjugated estrogens.
-
Phenobarbital
The enzyme inducer, phenobarbital, decreases the effect of the hormone agent, conjugated estrogens.
-
Phenytoin
The enzyme inducer, phenytoin, decreases the effect of the hormone agent, conjugated estrogens.
-
Prednisolone
The estrogenic agent may increase the effect of the corticosteroid, prednisolone.
-
Prednisone
The estrogenic agent may increase the effect of corticosteroid, prednisone.
-
Primidone
The enzyme inducer, primidone, decreases the effect of the hormone agent, conjugated estrogens.
-
Raloxifene
Association not recommended
-
Secobarbital
The enzyme inducer, secobarbital, decreases the effect of the hormone agent, conjugated estrogens.
-
Talbutal
The enzyme inducer, talbutal, decreases the effect of the hormone agent, conjugated estrogens.
-
Tipranavir
Conjugated estrogens may increase the adverse dermatological effects (i.e. skin rash) of Tipranavir. Tipranavir may decrease the serum concentration Conjugated estrogens. Monitor for estrogen deficiency during concomitant therapy.
-
Ursodeoxycholic acid
Estrogens decreases the effect of ursodiol
Liều Lượng & Cách Dùng :
Cream - Topical
Powder, for solution - Intravenous
Tablet - Oral
Dữ Kiện Thương Mại
Giá thị trường
-
Giá bán buôn : USD >1.42
Đơn vị tính : tablet
-
Giá bán buôn : USD >1.42
Đơn vị tính : tablet
-
Giá bán buôn : USD >1.42
Đơn vị tính : tablet
-
Giá bán buôn : USD >1.82
Đơn vị tính : tablet
-
Giá bán buôn : USD >1.83
Đơn vị tính : tablet
-
Giá bán buôn : USD >1.97
Đơn vị tính : tablet
-
Giá bán buôn : USD >1.97
Đơn vị tính : tablet
-
Giá bán buôn : USD >2.34
Đơn vị tính : tablet
-
Giá bán buôn : USD >2.34
Đơn vị tính : tablet
-
Giá bán buôn : USD >2.34
Đơn vị tính : tablet
-
Giá bán buôn : USD >2.34
Đơn vị tính : tablet
-
Giá bán buôn : USD >3.07
Đơn vị tính : g
-
Giá bán buôn : USD >69.99
Đơn vị tính : disp
-
Giá bán buôn : USD >107.54
Đơn vị tính : vial
-
Giá bán buôn : USD >134.05
Đơn vị tính : tube
-
Giá bán buôn : USD >0.11
Đơn vị tính : tablet
-
Giá bán buôn : USD >0.69
Đơn vị tính : g
Nhà Sản Xuất
-
Sản phẩm biệt dược : Cenestin
-
Sản phẩm biệt dược : ENJUVIA
-
Sản phẩm biệt dược : Premarin
-
Sản phẩm biệt dược : Premarin Vaginal
Tài Liệu Tham Khảo Thêm
National Drug Code Directory